Delivery Order SPE2DB22D3016-SPE2DB25FALK1

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,704.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product, and has an ultimate completion date of December 20, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $3,650.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is a delivery order for LO LOESTRIN FE 1-10 TABLET 28S, a type of oral contraceptive medication. The contract has an ultimate completion date of January 14, 2025 and uses a firm fixed price pricing structure. This award is part of a larger Indefinite Delivery Contract (IDC) valued...
This federal contract award is a delivery order with a firm fixed price valued at $1,910.89. It was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product, with a period of performance through March 24, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,613.57 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product, with a completion date of May 29, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LO LOESTRIN FE 1-10 TABLET 28S. The award has a ceiling value of $1,162.01 and a completion date of June 4, 2025. The contract is a Firm Fixed Price instrument and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,226.48 firm-fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a prescription medication. The contract has an ultimate completion date of February 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award, valued at $1,650.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,171.30 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a contraceptive medication. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,098.24 firm-fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S to support the Department of Defense (DoD) and other government agencies. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,701.24, is for the delivery of LO LOESTRIN FE 1-10 TABLET 28S, a prescription pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FALK1
    Delivery Order

This federal contract award, valued at $2,277.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a delivery order for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:08 AM